TY - JOUR T1 - Understanding the nature of face processing in early autism: A prospective study JF - medRxiv DO - 10.1101/2020.05.06.20092619 SP - 2020.05.06.20092619 AU - Charlotte Tye AU - Giorgia Bussu AU - Teodora Gliga AU - Mayada Elsabbagh AU - Greg Pasco AU - Kristinn Johnsen AU - Tony Charman AU - Emily J.H. Jones AU - Jan Buitelaar AU - Mark H. Johnson AU - the BASIS team Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/11/2020.05.06.20092619.abstract N2 - Dimensional approaches to psychopathology interrogate the core neurocognitive domains interacting at the individual level to shape diagnostic symptoms. Embedding this approach in prospective longitudinal studies could transform our understanding of the mechanisms underlying neurodevelopmental disorders. Such designs require us to move beyond traditional group comparisons and determine which domain-specific atypicalities apply at the level of the individual, and whether they vary across distinct phenotypic subgroups. As a proof of principle, this study examines how the domain of face processing contributes to a clinical diagnosis of Autism Spectrum Disorder (ASD). We used an event-related potentials (ERPs) task in a cohort of 8-month-old infants with (n=148) and without (n=68) an older sibling with ASD, and combined traditional case-control comparisons with machine-learning techniques like supervised classification for prediction of clinical outcome at 36 months and Bayesian hierarchical clustering for stratification into subgroups. Our findings converge to indicate that a broad profile of alterations in the time-course of neural processing of faces is an early predictor of later ASD diagnosis. Furthermore, we identified two brain response-defined subgroups in ASD that showed distinct alterations in different aspects of face processing compared to siblings without ASD diagnosis, suggesting that individual differences between infants contribute to the diffuse pattern of alterations predictive of ASD in the first year of life. This study shows that moving from group-level comparisons to pattern recognition and stratification can help to understand and reduce heterogeneity in clinical cohorts, and improve our understanding of the mechanisms that lead to later neurodevelopmental outcomes.General Scientific Summary This study suggests that neural processing of faces is diffusely atypical in Autism Spectrum Disorder, and that it represents a strong candidate predictor of outcome at an individual level in the first year of life.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by MRC Programme Grant no. G0701484 and MR/K021389/1, the BASIS funding consortium led by Autistica (www.basisnetwork.org), EU-AIMS (the Innovative Medicines Initiative joint undertaking grant agreement no. 115300, resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in-kind contribution), and AIMS-2-TRIALS (the Innovative Medicines Initiative 2 joint undertaking grant agreement no. 777394). Charlotte Tye is supported by a Tuberous Sclerosis Association fellowship and the NIHR Maudsley Biomedical Research Centre (BRC) at the Institute of Psychiatry, Psychology & Neuroscience and South London and Maudsley NHS Foundation Trust. Giorgia Bussu has received funding from the Marie Sklodowska Curie Actions of the European Community’s Horizon 2020 Program under grant agreement n°642996 (Brainview).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analysed during the current study are subject to the BASIS data sharing policy (http://www.basisnetwork.org/index.php?option=com_content&task=view&id=41&Itemid=68). ER -